593 related articles for article (PubMed ID: 32633046)
1. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.
Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ
Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046
[TBL] [Abstract][Full Text] [Related]
2. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.
Shi R; Radulovich N; Ng C; Liu N; Notsuda H; Cabanero M; Martins-Filho SN; Raghavan V; Li Q; Mer AS; Rosen JC; Li M; Wang YH; Tamblyn L; Pham NA; Haibe-Kains B; Liu G; Moghal N; Tsao MS
Clin Cancer Res; 2020 Mar; 26(5):1162-1174. PubMed ID: 31694835
[TBL] [Abstract][Full Text] [Related]
3. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
[TBL] [Abstract][Full Text] [Related]
4. Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC).
Lee SY; Cho HJ; Choi J; Ku B; Moon SW; Moon MH; Kim KS; Hyun K; Kim TJ; Sung YE; Hwang Y; Lee E; Ahn DH; Choi JY; Lim JU; Park CK; Kim SW; Kim SJ; Koo IS; Jung WS; Lee SH; Yeo CD; Lee DW
J Exp Clin Cancer Res; 2023 Nov; 42(1):309. PubMed ID: 37993887
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived organoids of non-small cells lung cancer and their application for drug screening.
Li YF; Gao Y; Liang BW; Cao XQ; Sun ZJ; Yu JH; Liu ZD; Han Y
Neoplasma; 2020 Mar; 67(2):430-437. PubMed ID: 31973535
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing.
Zu M; Hao X; Ning J; Zhou X; Gong Y; Lang Y; Xu W; Zhang J; Ding S
Biomed Pharmacother; 2023 Jul; 163():114751. PubMed ID: 37105073
[TBL] [Abstract][Full Text] [Related]
7. Establishment of patient-derived organoids for guiding personalized therapies in breast cancer patients.
Wu H; Wang W; Zhang Y; Chen Y; Shan C; Li J; Jia Y; Li C; Du C; Cai Y; Zhang Y; Zhang S; Wu F
Int J Cancer; 2024 Jul; 155(2):324-338. PubMed ID: 38533706
[TBL] [Abstract][Full Text] [Related]
8. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.
Pamarthy S; Sabaawy HE
Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine.
Taverna JA; Hung CN; Williams M; Williams R; Chen M; Kamali S; Sambandam V; Hsiang-Ling Chiu C; Osmulski PA; Gaczynska ME; DeArmond DT; Gaspard C; Mancini M; Kusi M; Pandya AN; Song L; Jin L; Schiavini P; Chen CL
Lung Cancer; 2024 Apr; 190():107533. PubMed ID: 38520909
[TBL] [Abstract][Full Text] [Related]
10. Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids.
Barbosa Rabago D; Blakely CM; Haderk F; Bivona TG
J Vis Exp; 2021 Nov; (177):. PubMed ID: 34866626
[TBL] [Abstract][Full Text] [Related]
11. Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response.
Smabers LP; Wensink E; Verissimo CS; Koedoot E; Pitsa KC; Huismans MA; Higuera Barón C; Doorn M; Valkenburg-van Iersel LB; Cirkel GA; Brousali A; Overmeer R; Koopman M; Braat MN; Penning de Vries B; Elias SG; Vries RG; Kranenburg O; Boj SF; Roodhart JM
J Exp Clin Cancer Res; 2024 Feb; 43(1):61. PubMed ID: 38414064
[TBL] [Abstract][Full Text] [Related]
12. Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma.
Kim SY; Kim SM; Lim S; Lee JY; Choi SJ; Yang SD; Yun MR; Kim CG; Gu SR; Park C; Park AY; Lim SM; Heo SG; Kim H; Cho BC
Clin Cancer Res; 2021 Aug; 27(15):4397-4409. PubMed ID: 34083237
[TBL] [Abstract][Full Text] [Related]
13. Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine.
Dijkstra KK; Monkhorst K; Schipper LJ; Hartemink KJ; Smit EF; Kaing S; de Groot R; Wolkers MC; Clevers H; Cuppen E; Voest EE
Cell Rep; 2020 May; 31(5):107588. PubMed ID: 32375033
[TBL] [Abstract][Full Text] [Related]
14. Development of a Single-Cell Technique to Increase Yield and Use of Gastrointestinal Cancer Organoids for Personalized Medicine Application.
Gao M; Harper MM; Lin M; Qasem SA; Patel RA; Mardini SH; Gabr MM; Cavnar MJ; Pandalai PK; Kim J
J Am Coll Surg; 2021 Apr; 232(4):504-514. PubMed ID: 33253861
[TBL] [Abstract][Full Text] [Related]
15. Gastric cancer patient-derived organoids model for the therapeutic drug screening.
Xu J; Gong J; Li M; Kang Y; Ma J; Wang X; Liang X; Qi X; Yu B; Yang J
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130566. PubMed ID: 38244703
[TBL] [Abstract][Full Text] [Related]
16. Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses.
de Witte CJ; Espejo Valle-Inclan J; Hami N; Lõhmussaar K; Kopper O; Vreuls CPH; Jonges GN; van Diest P; Nguyen L; Clevers H; Kloosterman WP; Cuppen E; Snippert HJG; Zweemer RP; Witteveen PO; Stelloo E
Cell Rep; 2020 Jun; 31(11):107762. PubMed ID: 32553164
[TBL] [Abstract][Full Text] [Related]
17. Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting.
Aizawa Y; Takada K; Aoyama J; Sano D; Yamanaka S; Seki M; Kuze Y; Ramilowski JA; Okuda R; Ueno Y; Nojima Y; Inayama Y; Hatakeyama H; Hatano T; Takahashi H; Nishimura G; Fujii S; Suzuki Y; Taniguchi H; Oridate N
Cell Oncol (Dordr); 2023 Apr; 46(2):409-421. PubMed ID: 36538240
[TBL] [Abstract][Full Text] [Related]
18. Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application.
Ren X; Huang M; Weng W; Xie Y; Wu Y; Zhu S; Zhang Y; Li D; Lai J; Shen S; Lin J; Kuang M; Li X; Yu J; Xu L
Cell Rep Med; 2023 Nov; 4(11):101277. PubMed ID: 37944531
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Surgical and Colonoscopy Tissue to Establish Colorectal Patient-derived Organoids.
Chen H; Yang Y; Shi J; Yan T; Wang J; Yang Y; Lu Q; Feng H; Du J; Cao Z; Weygant N
Curr Cancer Drug Targets; 2024; 24(5):546-555. PubMed ID: 37997804
[TBL] [Abstract][Full Text] [Related]
20. Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids.
Wang Z; Guo Y; Jin Y; Zhang X; Geng H; Xie G; Ye D; Yu Y; Liu D; Zhou D; Li B; Luo Y; Peng S; Li J
Cancer Cell Int; 2021 Oct; 21(1):519. PubMed ID: 34600546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
